Acridine-based agents with topoisomerase II activity inhibit pancreatic cancer cell proliferation and induce apoptosis

John R. Goodell, Andrei V. Ougolkov, Hiroshi Hiasa, Harneet Kaur, Rory Remmel, Daniel D. Billadeau, David M. Ferguson

Research output: Contribution to journalArticle

91 Scopus citations

Abstract

A series of substituted 9-aminoacridines is evaluated for antiproliferative activity toward pancreatic cancer cells. The results indicate that the compounds inhibit cell proliferation by inducing a G1-S phase arrest. A model is also developed that explains the molecular basis to inhibition through a DNA "threading" mechanism. We conclude that the drug-DNA complex formed blocks topoisomerase II binding and activity leading to catalytic inhibition of the enzyme and the induction of apoptosis and programmed cell death.

Original languageEnglish (US)
Pages (from-to)179-182
Number of pages4
JournalJournal of Medicinal Chemistry
Volume51
Issue number2
DOIs
StatePublished - Jan 24 2008

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'Acridine-based agents with topoisomerase II activity inhibit pancreatic cancer cell proliferation and induce apoptosis'. Together they form a unique fingerprint.

  • Cite this